BioVie Inc. (BIVI) Discusses Bezisterim Mechanism of Action and SUNRISE-PD Phase II Trial Design Transcript

SA Transcripts 161.79K Followers Follow BioVie Inc. ( BIVI ) Discusses Bezisterim Mechanism of Action and SUNRISE-PD Phase II Trial Design August 12, 2026 4:15 PM EDT Company Participants Cuong Viet Do - President, CEO & Director Joseph Palumbo - Executive VP of R&D and Chief Medical Officer Conference Call Participants Craig Brelsford Mark Stacy Presentation Craig Brelsford Hello. This is Craig Brelsford with RedChip Company. Thank you for joining today's event with BioVie, which trades on the NASDAQ under the ticker BIVI. With us today is Cuong Do, President and CEO of BioVie; Joe Palumbo, Chief Medical Officer of BioVie and Mark Stacy, a key opinion leader and the William E. Murray, Professor of Neurology, Movement Disorders Division at the Medical University of South Carolina. We will begin with a brief presentation in a moment and then we will answer your questions. Welcome to everyone joining us today on X, YouTube, LinkedIn and other social media platforms. [Operator Instructions] Before we begin, please allow me to read the safe harbor statement. This call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, along with other statements about the future expectations, beliefs, goals, plans or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact should also be considered forward-looking statements. Of course, forward-looking statements involve risks and uncertainties. Team BioVie, please go ahead. Cuong Viet Do President, CEO & Director Thank you, Craig, and thank you, everyone, for joining today. Before I start, I would like to thank everyone who's worked so hard for so many years to get us to where we are today. Our team has worked countless hours, sometimes pulling all-nighters and so forth, weekends, to get us here, right? And it's on their behalf that I'm speaking to you today regarding this. I would also